SCWorx Stock
SCWorx Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Timothy Andrew Hannibal
- Employees
- 9
- Market cap
- $22 M
- IPO
- 06/10/2016
SCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various…
SCWorx stock: price history
1D
-31.3%
1W
-63.0%
1M
-48.7%
6M
-89.8%
YTD
-95.9%
1Y
-97.4%
2Y
-99.4%
5Y
-100.0%
10Y
-100.0%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~24% weaker price swings than usual
Ask the agents about SCWorx
SCWorx stock metrics
P/E
-0.31
P/B
0.02
EV/EBITDA
14.63
RETURN ON EQUITY
-1.7%
NET MARGIN
-17.1%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.5%
FLOAT SHARES
15,764,871
AVG. DAILY VOLUME (30D)
658,521
Dividends & Stock splits
Comparable stocks
Frequently asked questions about SCWorx stock
What does SCWorx do?
SCWorx Corp. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Timothy Andrew Hannibal, the company employs around 9 people.
The IPO was on 06/10/2016; the stock trades on NASDAQ under the ticker WORX.
When does SCWorx report next?
Around past earnings, price swings were roughly -24% stronger than usual.
Does SCWorx pay a dividend?
No, SCWorx currently does not pay a dividend.
Which stocks are comparable to SCWorx?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get SCWorx stock analyzed?
Clicking "Analyze stock" lets five strategies assess SCWorx against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.